Analysts See $1.26 EPS for Walgreens Boots Alliance, Inc. (WBA)

Baystate Wealth Management LLC cut its position in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) by 1.5% during the first quarter, according to its most recent filing with the SEC. The firm has "Buy" rating by Needham given on Monday, July 17.

The consensus recommendation - averaging the work of 25 analysts - of 2.2 for Walgreens Boots Alliance, Inc.

Hedge funds and other institutional investors own 60.24% of the company's stock.

Walgreens Boots Alliance Inc. announced Wednesday it agreed to take a 40% minority stake in Chinese retail-pharmacy company Sinopharm Holding Guoda Drugstores Co. About 1.87 million shares traded or 3.64% up from the average. The P/S ratio for Walgreens Boots Alliance, Inc.is 0.6. Currently Tesla, Inc. (TSLA) stock is moving with Upswing trend.

NASDAQ:OPK) shares were trading lower by -1.95 percent ($-0.1) at $5.04 a piece in Tuesday's session. Finally, American Century Companies Inc. lifted its stake in Walgreens Boots Alliance by 1,145.3% in the 2nd quarter. Modera Wealth Management LLC now owns 2,451 shares of the pharmacy operator's stock valued at $204,000 after buying an additional 9 shares in the last quarter. Cornerstone Wealth Management LLC purchased a new stake in Walgreens Boots Alliance during the third quarter valued at $628,000. Looking at stock performance for the past six months, shares are -12.79%. The company has a quick ratio of 0.59, a current ratio of 1.07 and a debt-to-equity ratio of 0.45. During the last 52 weeks, the price has been as high as $88 and as low as $63.82. The company has a market cap of $69,503.16, a P/E ratio of 13.76, a price-to-earnings-growth ratio of 1.25 and a beta of 1.22. (NASDAQ:WBA) rating on Friday, October 27. The pharmacy operator reported $1.31 earnings per share for the quarter, topping the Zacks' consensus estimate of $1.21 by $0.10. The high and low revenue estimates for the current quarter are $30.66 Billion and $28.35 Billion, respectively. WBA has a net profit margin of 3.40% and is more profitable than the average company in the Drug Stores industry. During the same quarter in the prior year, the firm earned $1.31 EPS.

The shares of Walgreens Boots Alliance, Inc. have decreased by more than -14.15% this year alone.

Ranveer Singh back in yet another fesity attire
Shah Rukh Khan's dwarf movie and Rohit Shetty's Temper remake with Ranveer Singh are one of the most anticipated movies of 2018. Director Rohit Shetty's " Simmba " starring Ranveer Singh in the lead will hit the theatres on December 28 next year.

The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 12th. Stockholders of record on Monday, November 13th will be given a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a yield of 2.25%. Walgreens Boots Alliance's payout ratio is presently 42.33%. Vetr downgraded shares of Walgreens Boots Alliance from a "strong-buy" rating to a "buy" rating in a research note on Friday, December 1st. Private Vista LLC now owns 583,185 shares of the pharmacy operator's stock valued at $140,000 after purchasing an additional 574,218 shares during the last quarter.

Wall Street treaded water in choppy morning trading on Wednesday with gains in technology stocks offsetting losses in financial shares. The rating was reinitiated by Barclays Capital on Thursday, March 10 with "Equal-Weight". Raymond James Financial reaffirmed a "market perform" rating on shares of Walgreens Boots Alliance in a research note on Wednesday, September 27th.

When looking at the investment recommendation on say a scale of 1 to 5 (1 being a strong buy, 3 a hold, and 5 a sell), WBA is given a 2.20 while 2.90 placed for DISCA. Leerink Swann maintained the shares of WBA in report on Thursday, July 20 with "Buy" rating.

Among 29 analysts covering BB&T Corp (NYSE:BBT), 9 have Buy rating, 1 Sell and 19 Hold. Also, Director John Anthony Lederer acquired 20,000 shares of Walgreens Boots Alliance stock in a transaction on Thursday, October 26th. Finding the best stocks to add can take quite a bit of time, but putting in the extra analysis can provide a big boost to the portfolio. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, Director William C. Foote sold 2,736 shares of the firm's stock in a transaction dated Thursday, November 2nd. The average volume for the existing shares outstanding is 8057.28. Performance history gives insight to investors into the health of companies in which they invested. The disclosure for this purchase can be found here.

COPYRIGHT VIOLATION NOTICE: "Walgreens Boots Alliance Inc (WBA) Holdings Trimmed by Sprucegrove Investment Management Ltd." was published by TrueBlueTribune and is the sole property of of TrueBlueTribune. If you are reading this news story on another site, it was stolen and reposted in violation of U.S. and global copyright and trademark laws. The legal version of this piece of content can be viewed at https://www.truebluetribune.com/2017/12/07/walgreens-boots-alliance-inc-wba-stake-lessened-by-sprucegrove-investment-management-ltd.html. Currently, the 200-day MA for Walgreens Boots Alliance (WBA) is sitting at 79.07.

The performance for the week for Walgreens Boots Alliance, Inc.is -1.21% following the monthly performance of 7.75%. The Company's products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Latest News